Retour
30
Fourchette du Jour
6,27 €
6,68 €
Fourchette 52 Semaines
3,74 €
8,09 €
Volume
1 651 819
Moyenne 50J / 200J
7,01 €
/
5,87 €
Clôture Précédente
6,69 €
Quick Summary
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (633 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 254,9 | 0,2 |
| P/B | 1,6 | 2,8 |
| ROE % | 0,7 | 3,7 |
| Net Margin % | 0,7 | 3,9 |
| Rev Growth 5Y % | 20,9 | 9,7 |
| D/E | 0,1 | 0,2 |
Objectif de Cours des Analystes
Hold
9,30 €
+47.2%
Low: 8,00 €
High: 11,00 €
P/E Prévisionnel
90,97
BPA Prévisionnel
0,07 €
Croissance BPA (est.)
+0,0%
CA Est.
1,64B
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2028 |
0,33 €
0,22 € – 0,40 €
|
2,13B | 4 |
| FY2027 |
0,14 €
0,13 € – 0,15 €
|
1,87B | 4 |
| FY2026 |
0,07 €
0,06 € – 0,08 €
|
1,64B | 4 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-25 | 0,00 € | 0,03 € | +3291,5% |
| 2025-11-06 | -0,01 € | 0,00 € | +127,7% |
| 2025-08-07 | -0,03 € | -0,01 € | +66,7% |
| 2025-05-07 | -0,04 € | 0,00 € | +104,6% |
| 2025-02-27 | -0,04 € | -0,02 € | +50,0% |
| 2024-11-07 | -0,07 € | -0,02 € | +71,4% |
| 2024-08-08 | -0,07 € | -0,06 € | +14,3% |
| 2024-05-09 | -0,09 € | -0,06 € | +33,3% |
Dividend History
Yield
0,00%
Payout Ratio
0,00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Points Clés
Revenue grew 20,86% annually over 5 years — strong growth
ROE of 0,65% is below average
Debt/Equity of 0,13 — conservative balance sheet
Generating 110,03M in free cash flow
P/E of 254,93 — premium valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 7,01%
Croissance
Revenue Growth (5Y)
20,86%
Revenue (1Y)13,85%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
0,65%
ROIC1,12%
Net Margin0,68%
Op. Margin1,80%
Sécurité
Debt / Equity
0,13
Current Ratio1,65
Interest Coverage2,20
Valorisation
P/E Ratio
254,93
Forward P/E90,97
P/B Ratio1,62
EV/EBITDA93,71
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 13,85% | Revenue Growth (3Y) | 16,15% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 20,86% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 1,42B | Net Income (TTM) | 9,66M |
| ROE | 0,65% | ROA | 0,44% |
| Gross Margin | 28,53% | Operating Margin | 1,80% |
| Net Margin | 0,68% | Free Cash Flow (TTM) | 110,03M |
| ROIC | 1,12% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,13 | Current Ratio | 1,65 |
| Interest Coverage | 2,20 | ||
| Dividends | |||
| Dividend Yield | 0,00% | Payout Ratio | 0,00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 254,93 | Forward P/E | 90,97 |
| P/B Ratio | 1,62 | P/S Ratio | 1,73 |
| PEG Ratio | -2,34 | Forward PEG | N/A |
| EV/EBITDA | 93,71 | Fwd EV/EBITDA | 3,66 |
| Forward P/S | 1,51 | Fwd Earnings Yield | 1,10% |
| FCF Yield | 4,47% | ||
| Market Cap | 2,46B | Enterprise Value | 2,41B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1,42B | 1,25B | 1,06B | 859,54M | 667,51M |
| Net Income | 9,66M | -57,44M | -186,26M | -215,56M | -307,20M |
| EPS (Diluted) | 0,02 | -0,15 | -0,51 | -0,61 | -1,05 |
| Gross Profit | 406,35M | 402,40M | 302,10M | 237,02M | 201,51M |
| Operating Income | 25,71M | -31,61M | -189,13M | -210,17M | -286,35M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 2,20B | 2,12B | 2,11B | 2,17B | 1,93B |
| Total Liabilities | 682,92M | 672,01M | 681,04M | 655,15M | 382,08M |
| Shareholders' Equity | 1,52B | 1,45B | 1,43B | 1,52B | 1,55B |
| Total Debt | 194,10M | 485,19M | 511,04M | 478,83M | 158,74M |
| Cash & Equivalents | 248,64M | 154,57M | 78,82M | 108,62M | 148,03M |
| Current Assets | 416,20M | 312,51M | 225,73M | 233,22M | 266,52M |
| Current Liabilities | 251,96M | 228,89M | 202,87M | 176,00M | 116,75M |
Scores de Stratégies
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#829 of 1056
Activité Récente
Entré
Cash Flow Compounder
Mar 24, 2026